XRAY
28
2
SNA
68
-2
COF
60
2
NKE
36
6
ROP
62
3
DE
63
3
EXC
53
-3
NEE
50
-5
DNB
82
4
MSFT
50
3
PBI
69
4
F
58
11
VNO
60
10
SIG
52
3
HON
67
2
DVN
21
3
CL
58
2
NVDA
56
-4
AVY
53
3
STZ
54
-3
XRAY
28
2
SNA
68
-2
COF
60
2
NKE
36
6
ROP
62
3
DE
63
3
EXC
53
-3
NEE
50
-5
DNB
82
4
MSFT
50
3
PBI
69
4
F
58
11
VNO
60
10
SIG
52
3
HON
67
2
DVN
21
3
CL
58
2
NVDA
56
-4
AVY
53
3
STZ
54
-3
Financhill
Back

Willdan Group 10K Form

Buy
64

WLDN
Willdan Group

Last Price:
42.72
Seasonality Move:
4.01%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive WLDN News And Ratings

See the #1 stock for the next 7 days that we like better than WLDN

WLDN Financial Statistics

Sales & Book Value

Annual Sales: $510.1M
Cash Flow: $8.82M
Price / Cash Flow: 13.2
Annual Sales: $15.86
Price / Book: 2.69

Profitability

EPS (TTM): 1.63000
Net Income (TTM): $22.91M
Gross Margin: $179.77M
Return on Equity: 11.09%
Return on Assets: 5.47%

Willdan Group Earnings Forecast

Key Willdan Group Financial Ratios

  • The Gross Profit Margin over the past 23 years for WLDN is 35.24%.
  • The Selling, General & Administrative Expenses for WLDN have been equal to 27.69% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 86.15% of Operating Income.
  • The Net Earning history of WLDN is 2.14% of Total Revenues.
  • Per Share Earnings over the last 23 years have been positive in 11 years.

Willdan Group Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Professional Services
Sector: Industrials
Current Symbol: WLDN
CUSIP: 96924N
Website: willdan.com

Debt

Debt-to-Equity Ratio: 0.41
Current Ratio: 1.77
Quick Ratio: 1.73

Price-to-Earnings

Trailing P/E Ratio: 53.33
Forward P/E Ratio: 18.15

WLDN Technical Analysis vs Fundamental Analysis

Buy
64
Willdan Group (WLDN) is a Buy

Is Willdan Group a Buy or a Sell?

  • Willdan Group stock is rated a Buy
    The current Willdan Group [WLDN] share price is $42.66. The Score for WLDN is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.